The Global High Potency API Contract Manufacturing Market was worth US$ 8 billion in 2022 and is predicted to be worth US$ 16 billion by 2022-2032, at a CAGR of 7%. Because of the increasing incidence of cancer patients worldwide, the use of HPAPIs is increasing, which is boosting the market.
Rising breakthroughs in high potency API (HPAPI) manufacturing technologies, combined with the quest for more effective drugs to improve patient outcomes, have significantly increased the number of HPAPIs in development pipelines, accelerating industry growth. Furthermore, a rising tendency in outsourcing operations due to greater risk management, lower costs, and the availability of modern ways to HPAPI controls has fueled growth.
Download Sample Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-15786
Key Takeaways from the Market Study
- FMI projects the global high potency API Contract Manufacturing market to expand at a 7% value CAGR by 2032
- The global High Potency API Contract Manufacturing market is estimated at a market value of US$ 8 Billion
- The global high potency API contract manufacturing market is expected to garner a market value of US$ 16 Billion
- By application, oncology to experience major HPAPI contract manufacturing activities, yielding 63% of global revenue
“Demand for contract manufacturing of HPAPIs has expanded dramatically in recent years, and is one of the primary drivers of the global HPAPI market, owing to a rising number of prospective phase 3 drug candidates.”Says an analyst at FMI
Market Competition
Piramal Pharma Solutions, Lonza, Catalent, Inc., VxP Pharma, Inc., Pfizer CentreOne, Gentec Pharmaceutical Group, AbbVie, Aurigene Pharmaceutical Services Ltd., CordenPharma International and Curia Global, Inc., are some prominent High Potency API Contract Manufacturing manufacturers.
- InJune 2021, Lonza, for example, spent USD 21.5 billion in its Nansha, China, plant to enhance its API development and manufacturing capacity. Three 1,000 L GMP trains totalling 12 cu. ft. of reactor volume m. Additional expenditures will be made, as well as new research and GMP facilities capable of creating small-scale batches of highly effective APIs
Inquire Before Buying Research Report: https://www.futuremarketinsights.com/ask-question/rep-gb-15786
Key Segments Profiled in the High Potency API Contract Manufacturing Market Industry Survey
High Potency API Contract Manufacturing Market by Product Type:
- Innovative
- Generic
High Potency API Contract Manufacturing Market by Synthesis:
- Synthetic
- Biotech
High Potency API Contract Manufacturing Market by Application:
- Oncology
- Hormonal Disorders
- Glaucoma
- Others
Pre-Book Report: https://www.futuremarketinsights.com/checkout/15786
High Potency API Contract Manufacturing Market by Dosage Form:
- Injectable
- Oral Solids
- Creams
- Others